Medreich Fexofenadine

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Fexofenadine hydrochloride 120 mg;  
Available from:
Medreich New Zealand Limited
INN (International Name):
Fexofenadine hydrochloride 120 mg
Dosage:
120 mg
Pharmaceutical form:
Film coated tablet
Composition:
Active: Fexofenadine hydrochloride 120 mg   Excipient: Colloidal silicon dioxide Croscarmellose sodium Hypromellose E-5 Opadry pink 00A94480 Macrogol 6000 Magnesium stearate Mannitol   Silicified microcrystalline cellulose
Prescription type:
Pharmacy only
Manufactured by:
Virupaksha Organics Pvt. Ltd.
Therapeutic indications:
Relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years or older
Product summary:
Package - Contents - Shelf Life: Blister pack, PVC/PVdC/Al - 10 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PE/ACLAR - 10 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PVdC/Al - 20 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PE/ACLAR - 20 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PE/ACLAR - 30 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PVdC/Al - 30 tablets - 36 months from date of manufacture stored at or below 30°C
Authorization number:
TT50-9936c
Authorization date:
2016-01-22

Similar products

Search alerts related to this product

Share this information